Member Info for researcher1

I've enrolled for it so will post details nearer the time....

should be up all the way, but we'll see.... Note the conference on Jan 27 pitched at US investors, so expect some action either side of that. FDA could be as early as March. HNY!

a series of very strange small trades going through on the 23rd - ideas anyone?

agreed, but no one will pay that for it 'up front' - an offer would come in much lower
anyhow, we'll see - it could be tasty - Xmas - New Year period could be last chance to get in cheaply....

GLA for a fantastic 4D rise in 2021

I agree that £1 is nearer current IP value, but that is way too much of a premium. We'd be lucky to get 50p, and I'm with Feeks, in that 30p would be a snip, but I'd accept it after all this waiting....
I've loaded up more in preparation...

it's beginning to look a lot like Christmas ....

yep, plenty of action booked in for January, regardless of bungling Boris. I have the sneaking suspicion of a takeover bid.....

there's sustained buying out there as well now - and we should have a couple of bits of news in January (clinics and ovarian trials) to spice things up before the main dish in the spring.... Happy Christmas all you ANGLErs.... 2021 is our year!

yep, pretty mysterious....

odd trading day today - huge sell of £133K then enough buys to wipe it out - wonder who that was?

Malachi, as I previously posted, I asked the company yesterday for clarification on Jupiter, and AN himself confirmed by email that they now hold zero shares.
You will need to blame someone else.
Look no further than traders who bought in at 38.5 and don't want to wait for FDA clearance...

best to ignore these games though - after Nasdaq we are talking about 2x current Sp for starters....

BreX your £4 tallies with AN's target (not least because it unlocks his bonus payments...)

but maybe we should move on - I don't think BreX appreciates the magnitude of the opportunity for Parsortix - leadership (nay, domination) of an annual £8M liquid biopsy market - the sums in,say, three years' time, are eye-watering. There will be predators about... just a question of when they might move - before FDA would be the canny play - a few hundred million would be small change to big pharma - or they may end up paying 10 times that.

some of the big sells are actually delayed buys (e.g. the £40K). I had a message from AN this morning confirming Jupiter have gone - and maybe the new shareholding register has inspired confidence ....

br3xiUK is not British! even funnier....

ha ha - what a joke you are!

it is likely to be very lumpy on the way up - firstly we'll have profit takers who got in at 39, creating resistance around 43, then the placees from 46 (some of whom may have bought more) so resistance around 48/49, then the US investors (in at 60p) many of whom will have doubled down, meaning 56/57 could be top slice territory for them. Once we are at 60p we should be able to take a breather....

this figure of 80% from Finncap keeps being bandied around as if it is gospel! A better grasp of the likely result of a Q process is that "it will be successful" - the question is only whether the FDA will ask for further clarifications or details. As long as Angle are clear and persistent, it will succeed - there is no patient safety to take into account - it is an issue of precision, accuracy and specificity, and these have already been proven elsewhere. Just my take, of course....